[Form 4] Air Products & Chemicals, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Air Products & Chemicals, Inc. director Bhavesh V. Patel acquired 124.734 phantom deferred stock units on 09/30/2025 under the Companys Deferred Compensation Program for Directors. The filing states these Units are part of the Long-Term Incentive Plan and later convert to an equal number of common shares when paid, generally after the directors board service ends; payment can be a lump sum or up to ten installments as elected in advance. The transaction was reported on a Form 4 filed by one reporting person and signed by an attorney-in-fact on 10/02/2025.
Positive
- Director received 124.734 phantom deferred stock units under the Company's Deferred Compensation Program for Directors
- Units convert to an equal number of common shares when paid, as stated in the filing
- Payment options are flexible: lump sum or up to ten installments as elected by the reporting person
Negative
- None.
Insights
TL;DR: Director received deferred phantom units that convert to shares after service, aligning compensation with equity.
The Form 4 documents a non-cash grant of 124.734 phantom deferred stock units to Director Bhavesh V. Patel under the company's Deferred Compensation Program for Directors tied to the Long-Term Incentive Plan. The filing explicitly states these Units convert to the same number of common shares when paid and may be distributed as a lump sum or in up to ten installments at the reporting person's election. This is a routine, non-derivative compensation disclosure with no cash sale or purchase recorded.
TL;DR: Routine Section 16 filing showing acquisition of phantom units; no derivative exercises or dispositions reported.
The document shows a single transaction date of 09/30/2025 coded as an acquisition (A) of 124.734 phantom stock units with a reported per-unit price of $270.48 and resulting beneficial ownership of 816.3689 shares indicated. The Form 4 was filed by one reporting person and executed via attorney-in-fact on 10/02/2025. The disclosure is procedural and consistent with deferred-compensation reporting requirements under Section 16.